Event chart PROTAGONIST THERAPEUTICS, INC. |
|
|
Upcoming events on PROTAGONIST THERAPEUTICS, INC. |
|
03/08/23 | | FY 2022 Earnings Release (Projected) |
05/10/23 | | Q1 2023 Earnings Release (Projected) |
08/08/23 | | Interim 2023 Earnings Release (Projected) |
11/07/23 | | Q3 2023 Earnings Release (Projected) |
|
Past events on PROTAGONIST THERAPEUTICS, INC. |
|
01/09/23 | 11:00am | | JP Morgan Healthcare Conference |
12/12/22 | | American society of hematology meeting - session name: 102 |
12/12/22 | | American society of hematology meeting - session name: 634 |
12/10/22 | 06:30pm | | American society of hematology meeting - session name: 634 |
12/06/22 | 11:40am | | JMP Securities Hematology Oncology Summit |
11/08/22 | 04:05pm | | Q3 2022 Earnings Release |
10/10/22 | 12:30pm | | United European Gastroenterology Week - Abstract #ASUEG202203120 |
08/04/22 | 04:05pm | | Interim 2022 Earnings Release |
06/08/22 | 09:30am | | Jefferies Healthcare Conference |
06/07/22 | 11:45am | | American society of clinical oncology meeting - abstract number: #7003 |
|
Past dividends on PROTAGONIST THERAPEUTICS, INC. |
|
- No events available -
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 20,1 17,7 14% | 30,9 33,6 -8,0% | 0,23 1,74 -87% | 28,6 25,7 11% | 27,4 23,2 18% | 31,5 |
Operating income (EBITDA) M $ |
Released Forecast Spread |
|
|
| -63,7 -68,7 7,2% | -125 -135 7,4% | -128 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -37,9 -42,0 9,8% | -42,3 -38,2 -11% | -80,5 -81,8 1,5% | -64,5 -65,4 1,3% | -126 -128 1,5% | -128 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -37,0 -41,0 9,9% | -39,7 -37,8 -5,1% | -77,9 -79,3 1,8% | -64,8 -64,1 -1,1% | -126 -128 2,1% | -127 |
Net income M $ |
Released Forecast Spread | -37,0 -41,0 9,9% | -38,9 -36,0 -8,0% | -77,2 -77,9 0,89% | -66,2 -66,2 0,04% | -126 -128 1,9% | -127 |
EPS $ |
Released Forecast Spread | -2,09 -2,29 8,9% | -1,74 -1,67 -4,4% | -2,98 -3,00 0,60% | -1,92 -1,94 0,84% | -2,71 -2,73 0,78% | -2,56 | Announcement Date | 03/07/2018 | 03/12/2019 | 03/10/2020 | 03/10/2021 | 02/28/2022 | - |
|
|
Fiscal Period : December | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
Sales M $ |
Released Forecast Spread | 13,1 2,15 510% | 5,65 2,70 109% | 6,19 1,50 313% | 2,27 5,00 -55% | 10,3 1,74 490% | 8,62 4,44 94% | 25,7 17,1 51% | 0,86 0,38 124% |
| 5,00 | 3,33 | 1,67 | 6,67 | 5,83 |
Operating income (EBITDA) M $ |
Released Forecast Spread |
| -18,6 -23,0 19% | -23,8 -26,0 8,3% | -30,7 -31,0 0,98% | -33,7 -35,0 3,7% | -36,8 -46,0 20% | -20,9 -50,0 58% | -41,2 -52,0 21% | -32,0 -43,0 26% | -33,0 |
|
|
|
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -7,77 -22,1 65% | -18,8 -19,7 4,3% | -24,0 -24,3 1,1% | -30,9 -25,1 -23% | -33,9 -31,5 -7,8% | -37,0 -39,0 5,0% | -21,1 -27,8 24% | -41,4 -46,3 11% | -32,3 -43,3 25% | -32,2 | -43,1 | -39,0 | -35,1 | -28,5 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -7,76 -21,8 64% | -18,9 -18,2 -4,0% | -24,0 -12,6 -91% | -30,8 -30,9 0,27% | -33,8 -33,0 -2,4% | -36,9 -39,4 6,4% | -20,9 -31,6 34% | -41,0 -48,9 16% | -31,2 -41,7 25% | -33,6 | -43,1 | -39,0 | -35,1 | -28,5 |
Net income M $ |
Released Forecast Spread | -7,76 -21,5 64% | -18,9 -18,1 -4,5% | -24,0 -24,2 0,87% | -30,8 -25,1 -23% | -33,8 -31,8 -6,2% | -36,9 -39,3 6,1% | -20,9 -30,4 31% | -41,0 -45,9 11% | -31,2 -43,0 27% | -32,0 | -38,0 | -36,2 | -34,3 | -31,3 |
EPS $ |
Released Forecast Spread | -0,21 -0,61 66% | -0,48 -0,48 -0,60% | -0,54 -0,57 5,1% | -0,69 -0,54 -28% | -0,70 -0,68 -2,6% | -0,77 -0,79 2,4% | -0,43 -0,63 32% | -0,84 -0,94 10% | -0,64 -0,87 26% | -0,64 | -0,69 | -0,71 | -0,63 | -0,66 | Announcement Date | 11/04/2020 | 03/10/2021 | 05/04/2021 | 08/04/2021 | 11/03/2021 | 02/28/2022 | 05/04/2022 | 08/04/2022 | 11/08/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for PROTAGONIST THERAPEUTICS, INC. |
|
|
|
Past sector events for PROTAGONIST THERAPEUTICS, INC. |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|